We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
Cap. Flow
+$469M
Cap. Flow %
8.38%
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 15.15%
3 Healthcare 14.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHLT
901
DELISTED
Performant Healthcare Inc
PHLT
$204K ﹤0.01%
69,160
-9,900
-13% -$21.8K
LYV icon
902
Live Nation Entertainment
LYV
$41.2B
$203K ﹤0.01%
7,380
-206,390
-97% -$5.38M
ALSK
903
DELISTED
Alaska Communications Systems
ALSK
$203K ﹤0.01%
117,997
-7,100
-6% -$12K
ATO icon
904
Atmos Energy
ATO
$29.9B
$202K ﹤0.01%
2,710
-310
-10% -$23.9K
SHOS
905
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$202K ﹤0.01%
40,893
-2,300
-5% -$14.3K
PRU icon
906
Prudential Financial
PRU
$41.7B
$201K ﹤0.01%
+2,460
New +$189K
SYNC
907
DELISTED
Synacor, Inc.
SYNC
$201K ﹤0.01%
69,079
SCX
908
DELISTED
The L.S. Starrett Company
SCX
$200K ﹤0.01%
20,343
-2,000
-9% -$22.6K
PAR icon
909
PAR Technology
PAR
$637M
$198K ﹤0.01%
36,892
VATE icon
910
INNOVATE Corp
VATE
$114M
$197K ﹤0.01%
+3,610
New +$166K
LBY
911
DELISTED
Libbey, Inc.
LBY
$197K ﹤0.01%
11,050
-25,978
-70% -$454K
BHBK
912
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$197K ﹤0.01%
13,100
SPRT
913
DELISTED
support.com, Inc.
SPRT
$196K ﹤0.01%
77,642
-19,408
-20% -$50.5K
KDNY
914
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$195K ﹤0.01%
3,142
-5,058
-62% -$358K
TVPT
915
DELISTED
Travelport Worldwide Limited
TVPT
$191K ﹤0.01%
12,700
MNTX
916
DELISTED
Manitex International, Inc.
MNTX
$191K ﹤0.01%
+34,655
New +$221K
CBIO
917
Crescent Biopharma
CBIO
$602M
$190K ﹤0.01%
266
-21
-7% -$16.1K
PRGX
918
DELISTED
PRGX Global, Inc.
PRGX
$189K ﹤0.01%
40,058
-13,700
-25% -$67.2K
CASC
919
DELISTED
Cascadian Therapeutics, Inc.
CASC
$189K ﹤0.01%
19,222
-24,300
-56% -$172K
MXPT
920
DELISTED
MaxPoint Interactive, Inc.
MXPT
$187K ﹤0.01%
20,967
+6,630
+46% +$66.2K
FSP
921
Franklin Street Properties
FSP
$44.8M
$181K ﹤0.01%
+14,400
New +$181K
WMAR
922
DELISTED
West Marine Inc
WMAR
$180K ﹤0.01%
21,800
FDC
923
DELISTED
First Data Corporation
FDC
$178K ﹤0.01%
13,550
-807,367
-98% -$10.4M
BWEN icon
924
Broadwind
BWEN
$113M
$176K ﹤0.01%
39,900
-14,600
-27% -$66.7K
NVTR
925
DELISTED
Nuvectra Corporation Common Stock
NVTR
$174K ﹤0.01%
+25,182
New +$173K

Similar funds

Jacobs Levy Equity Management's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
  • Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
  • Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
  • Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
  • Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
  • Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.